A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback